Prognostic factors of perioperative FLOT regimen in operable gastric and gastroesophageal junction tumors: real-life data (Turkish Oncology Group)


Creative Commons License

Erol C., Sakin A., BAŞOĞLU TÜYLÜ T., Ozden E., ÇABUK D., Dogan M., ...More

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.52, no.4, pp.1022-1032, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 52 Issue: 4
  • Publication Date: 2022
  • Doi Number: 10.55730/1300-0144.5404
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1022-1032
  • Keywords: FLOT chemotherapy, perioperative treatment, gastric cancer, GEJ tumor, prognostic factor, NEUTROPHIL-LYMPHOCYTE RATIO, CHEMOTHERAPY, ADENOCARCINOMA, SURVIVAL, PLATELET, NOMOGRAM, SURGERY, CANCER
  • Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Background/aim: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in real-life gastric and GEJ tumors.